Cerus (CERS) Corporation announced two in-country regulatory approvals for INT200, its next-generation LED-based illumination device. The approvals were from the French National Agency for Medicines and Health Product Safety and the Swiss Agency for Therapeutic Products. These approvals follow the CE Mark authorization received in March. Cerus expects to convert its installed base of INT100s in EMEA to INT200s over the next three years and plans a PMA submission to the FDA during 2026.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERS: